drugset / Trial / NCT00691912

Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin

NCT00691912 ↗

Phase 2 Terminated 26 enrolled Claudia Lorenz-Schlüter
NaSingle-groupOpen-labelTreatment

Summary

Today metastatic breast cancer is regarded as cureless. The treatment is palliative in intent and the goals of treatment include improvement of quality of life and if possible prolongation of life. Treatment in metastatic cancer will usually involve hormone therapy and/or chemotherapy. Weekly application of chemotherapeutical drugs may lead to less drug concentrations in healthy tissue and therefore toxicities maý be reduced.

Timeline

Start
2006-12
Primary completion
2013-12
Completion
2013-12

Outcome

Outcome not reported

Stopped: “Study was stopped due because recrutation.was much slower as anticipated.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxorubicin Other / unclassified 20 mg/m2 —
Subject Paclitaxel Small molecule 80 mg/m2 —

Indications